Evidence map›Paper›PMID 42178814›Full record

ArticleAmerican journal of respiratory and critical care medicine2026

Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE.

Eleanor M Dunican, Mario Castro, Alberto Papi, Vibeke Backer, Christopher E Brightling, Arnaud Bourdin, Johann Christian Virchow, Arman Altincatal, Rebecca Gall, Hashem Awad and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Eleanor M DunicanEducation and Research Centre, St. Vincent's Hospital, Dublin, Ireland.ORCID 0000-0003-4014-5100
Mario CastroDepartment of Medicine, University of Kansas School of Medicine, Kansas City, KS, United States.
Alberto PapiDepartment of Cardiorespiratory Medicine, Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy.
Vibeke BackerDepartment of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet University Hospital, Copenhagen, Denmark.
Christopher E BrightlingDepartment of Respiratory Sciences, Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.
Arnaud BourdinDepartment of Respiratory Diseases, PhyMedExp, University of Montpellier, INSERM CNRS, Montpellier, France.
Johann Christian VirchowDepartments of Pneumology and Intensive Care Medicine, University of Rostock, Rostock, Germany.
Arman AltincatalSanofi, Cambridge, MA, United States.
Rebecca GallRegeneron Pharmaceuticals Inc, Tarrytown, NY, United States.
Hashem AwadSanofi, Cambridge, MA, United States.
Njira L LugogoMichigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, United States.

Funding

ClinicalTrials.gov Identifier NCT04400318Good Publication Practice GPP 2022Sanofi and Regeneron Pharmaceuticals Inc
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42178814
PMCPMC13424600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.